PPARδ raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-17. Anything still debated is marked as such rather than presented as settled.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516, GW-501516, GW 501516, endurobol | Names vary in research and anti-doping documents. |
| Chemical class | Synthetic PPARδ agonist | Small-molecule nuclear receptor ligand. |
| CAS Registry Number | 317318-70-0 | Identifier commonly associated with GW501516. |
| Appearance | White to off-white powder | Typical for purified research material. |
| Solubility | Low in water; soluble in DMSO and ethanol | Organic solvents are common for laboratory stock solutions. |
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
==== Phospholipases ==== Phospholipase is an enzyme that transforms the phospholipid molecule into a lysophospholipid (soap) → the new molecule attracts and binds fat and ruptures cell membranes. Phospholipase A2 is one specific type of phospholipases found in snake venom. Snake example: Okinawan habu (Trimeresurus flavoviridis)
By August 1978, the Genentech scientists were able to synthesize human insulin, and in that same month, Swanson and colleagues negotiated a multimillion-dollar contract with Eli Lilly. The big company-small company relationship they developed became the eventual template for other biotechnology start ups. While there was still plenty of work to be done on the human insulin synthesis, the new stream of revenues and the significant amount of media coverage meant that Genentech could pursue other research projects. By 1979, Genentech had projects on interferons, animal growth hormones, hepatitis B vaccines, and the hormone thymosin. By 1980, Swanson decided that they should raise money by making Genentech public. This was due to a variety of factors. Genentech needed more money to continue its development, and Swanson believed that the public interest in the technology should be capitalized on. The initial public offering took place on October 14, 1980, and it was the largest IPO ever, at that moment in history, with Genentech raising 35 million dollars. A trip to Europe in September 1980 to raise interest from European investors before the IPO also served as his honeymoon. From here on, Swanson would focus on pursuing his vision of Genentech as a self sustainable biotechnology company, not a contract research operation. He believed that recombinant growth hormones had a large market in the United States, and that they would be key for Genentech's corporate evolution.
== Education == Fernandez received licentiate degrees in chemistry (1979) and mathematics (1980) from the Universidad Nacional del Sur, Argentina. He then earned a Ph.D. from Yale University in 1984 with a thesis entitled Structural Stability of Chemical Systems at Critical Regimes.
The first scientists to determine relative atomic masses were John Dalton and Thomas Thomson between 1803 and 1805 and Jöns Jakob Berzelius between 1808 and 1826. Relative atomic mass (Atomic weight) was originally defined relative to that of the lightest element, hydrogen, which was taken as 1.00, and in the 1820s, Prout's hypothesis stated that atomic masses of all elements would prove to be exact multiples of that of hydrogen. Berzelius, however, soon proved that this was not even approximately true, and for some elements, such as chlorine, relative atomic mass, at about 35.5, falls almost exactly halfway between two integral multiples of that of hydrogen. Still later, this was shown to be largely due to a mix of isotopes, and that the atomic masses of pure isotopes, or nuclides, are multiples of the hydrogen mass, to within about 1%. In the 1860s, Stanislao Cannizzaro refined relative atomic masses by applying Avogadro's law (notably at the Karlsruhe Congress of 1860). He formulated a law to determine relative atomic masses of elements: the different quantities of the same element contained in different molecules are all whole multiples of the atomic weight and determined relative atomic masses and molecular masses by comparing the vapor density of a collection of gases with molecules containing one or more of the chemical element in question. In the 20th century, until the 1960s, chemists and physicists used two different atomic-mass scales.
Sources: en.wikipedia.org
=== Fungi === Fungi, notably zygomycetes, ascomycetes, and higher basidiomycetes, regardless of sporulation, are able to be stored in liquid nitrogen or deep-frozen. Cryopreservation is a hallmark method for fungi that do not sporulate (otherwise other preservation methods for spores can be used at lower costs and ease), sporulate but have delicate spores (large or freeze-dry sensitive), are pathogenic (dangerous to keep metabolically active fungus) or are to be used for genetic stocks (ideally to have an identical composition as the original deposit). As with many other organisms, cryoprotectants like DMSO or glycerol (e.g. filamentous fungi 10% glycerol or yeast 20% glycerol) are used. Differences between choosing cryoprotectants are species (or class) dependent, but generally for fungi penetrating cryoprotectants like DMSO, glycerol or polyethylene glycol are most effective (other non-penetrating ones include sugars mannitol, sorbitol, dextran, etc.). Freeze-thaw repetition is not recommended as it can decrease viability. Back-up deep-freezers or liquid nitrogen storage sites are recommended. Multiple protocols for freezing are summarized below (each uses screw-cap polypropylene cryotubes):
5G cellular network – next-generation cellular networks which began deployment in 2019. Their major advantage is much higher data rates than previous cellular networks, up to 10 Gbps; 100 times faster than the previous cellular technology, 4G LTE. The higher data rates are achieved partly by using higher frequency radio waves, in the higher microwave band 3–6 GHz, and millimeter wave band, around 28 and 39 GHz. Since these frequencies have a shorter range than previous cellphone bands, the cells will be smaller than the cells in previous cellular networks which could be many miles across. Millimeter-wave cells will only be a few blocks long, and instead of a cell base station and antenna tower, they will have many small antennas attached to utility poles and buildings.
=== Diver's telephone === The communications equipment is relatively straightforward and may be of the two-wire or four-wire type. Two wire systems use the same wires for surface to diver and diver to surface messages, whereas four wire systems allow the diver's messages and the surface operator's messages to use separate wire pairs. In a two wire system the standard arrangement for diver communications is to have the diver's side normally on, so that the surface team can hear anything from the diver at all times except when the surface is sending a message. In a four-wire system the diver's side is always on, even when the surface operator is talking. This is considered an important safety feature, as the surface team can monitor the diver's breathing sounds, which can give early warning of problems developing, and confirms that the diver is alive. Heliox divers may need a decoder system (unscrambler) which reduces the frequency of the sound to make it more intelligible.
Plant, microbe, and insect chemical ecology focuses on the role of chemical cues and signals in mediating interactions with their abiotic (e.g. ability of some bacterium to reduce metals in the surrounding environment) and biotic environment (e.g. microorganisms, phytophagous insects, and pollinators). Cues allow for organisms to monitor interactions with the environment and to adjust accordingly through changes in chemical abundance as a response. Changes in compound abundance allows for defensive measures to be enacted, e.g. attracts for predators.
Typically, the complete breakdown of one molecule of glucose by aerobic respiration (i.e. involving glycolysis, the citric-acid cycle and oxidative phosphorylation, the last providing the most energy) is usually about 30–32 molecules of ATP. Oxidation of one gram of carbohydrate yields approximately 4 kcal of energy.
Sources: en.wikipedia.org
Since this went too far for the Centre's national leadership, the negotiations were transferred to the national level, where Heinrich Brüning conferred with Gregor Strasser. During that period the anti-Nazi polemics ceased in order not to disturb the negotiations. Since the NSDAP was the larger party, the Centre was willing to accept a Nazi as Chancellor, provided he could gain the trust of the President, which at that time seemed quite a difficult task. The negotiations were bound for failure, since the aims of the two groups were largely incompatible. The Centre argued that the vote of July had "called Hitler not to dictatorship but to responsibility, to getting in line with law and constitution". They hoped to "build a strong government without touching the substance of the constitution", to create "clear responsibilities" and to "preclude anti-constitutional experiments". The Centre advocated a return to Brüning's "authoritarian democracy", which they considered up to the times and tested by experience, against Papen's "omnipotent state and independent leadership", while the Nazis would only accept a coalition that would serve their purpose of achieving total dominance. Not expecting a successful conclusion, Hitler used the Centre negotiations in order to put pressure on the Papen administration. The negotiations were also met with criticism from within the Centre Party. Some rejected them as "currying favour with the National Socialists" and giving credence to Hitler's strategy of legality.
== Identification == S. haemolyticus can be identified on the species level using a variety of manual and automated methods. The most frequently employed are: the reference method (based on growth tests), API ID 32 Staph (bioMe´rieux), Staph-Zym (Rosco), UZA (a rapid 4-h method), and polymerase chain reaction and electrophoretic analysis of the 16S rRNA, hsp60, or sodA gene sequence. Preference towards a particular method usually depends on convenience, economics, and required specificity (some species have identical 16S rRNA). The most closely related species of S. haemolyticus is Staphylococcus borealis.
As with animal findings, both TMPAA and NAM have been said to be inactive based on human tests. It has also been noted that metabolites like TMPA and TMPE are rapidly metabolized. As such, metabolites of mescaline like TMPA, TMPE, TMPAA, and NAM do not appear to be involved in the drug's psychedelic-related effects. 3,4,5-Trimethoxyamphetamine (TMA), the α-methyl analogue of mescaline and an MAO-resistant psychedelic, is only about twice as potent as mescaline as a psychedelic in humans despite having similar serotonin receptor affinity. This suggests that the deamination of mescaline has a relatively limited impact on its potency, compared to for example the 2C series of psychedelics. Another analogue of mescaline, the deuterated isotopologue Alpha-D (α,α-dideuteromescaline), has been reported to be roughly one-third more potent than mescaline as a psychedelic in humans, albeit based on limited testing. This is consistent with findings of about one-third of a dose of mescaline being metabolized via deamination.
Chemists use the study of intramolecular and intermolecular non-covalent bonding/interactions in molecules to evaluate reactivity. Such interactions include, but are not limited to, hydrogen bonding, electrostatic interactions between charged molecules, dipole-dipole interactions, polar-π and cation-π interactions, π-stacking, donor-acceptor chemistry, and halogen bonding. In addition, the hydrophobic effect—the association of organic compounds in water—is an electrostatic, non-covalent interaction of interest to chemists. The precise physical origin of the hydrophobic effect originates from many complex interactions, but it is believed to be the most important component of biomolecular recognition in water. For example, researchers elucidated the structural basis for folic acid recognition by folate acid receptor proteins. The strong interaction between folic acid and folate receptor was attributed to both hydrogen bonds and hydrophobic interactions. The study of non-covalent interactions is also used to study binding and cooperativity in supramolecular assemblies and macrocyclic compounds such as crown ethers and cryptands, which can act as hosts to guest molecules.
== Veterinary use == Meloxicam is used in veterinary medicine mainly to treat dogs, but also sees off-label use in other animals such as cattle and exotics. In the European Union and other countries it is not considered off-label and can be used in cattle, pigs, horses, dogs, cats and guinea pigs. It has also been investigated as an alternative to diclofenac by the Royal Society for the Protection of Birds (RSPB) to prevent deaths of vultures. Depending on the animal species, each country or union of countries applies different guidelines or legal frameworks for the use of the drug, as well as different recorded side effects. The most common side effects in dogs include gastrointestinal irritation (vomiting, diarrhea, and ulceration). As far as the perioperative administration is concerned, in healthy dogs given meloxicam, no perioperative adverse effects on the cardiovascular system have been reported at recommended dosages. Perioperative administration of meloxicam to cats did not affect postoperative respiratory rate nor heart rate.
Sources: en.wikipedia.org
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.
No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.
Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.